TGFβ signaling promotes cell cycle progression and resistance to the CDK4/6 inhibitor palbociclib through SOX4 transcriptional modulation in breast cancer cells
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 40 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 40 samples: 12 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- TGFβ signaling promotes cell cycle progression and resistance to the CDK4/6 inhibitor palbociclib through SOX4 transcriptional modulation in breast cancer cellsCell death & disease · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE300358_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1280147 and SRA study SRP593491. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 40 samples.
How we read this: 12 replicated groups read from 40 sample titles; they account for 40 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9059024 MDA-MB-231_Csi-1 MDA-MB-231_Csi
- GSM9059025 MDA-MB-231_Csi-2 MDA-MB-231_Csi
- GSM9059026 MDA-MB-231_Csi-3 MDA-MB-231_Csi
- GSM9059027 MDA-MB-231_SMAD_KD-1 MDA-MB-231_SMAD_KD
- GSM9059028 MDA-MB-231_SMAD_KD-2 MDA-MB-231_SMAD_KD
- GSM9059029 MDA-MB-231_SMAD_KD-3 MDA-MB-231_SMAD_KD
- GSM9059030 MI-Ctrl-1 MI-Ctrl
- GSM9059031 MI-Ctrl-2 MI-Ctrl
- GSM9059032 MI-Ctrl-3 MI-Ctrl
- GSM9059033 MI-TGFb-1 MI-TGFb
- GSM9059034 MI-TGFb-2 MI-TGFb
- GSM9059035 MI-TGFb-3 MI-TGFb
- GSM9059036 MII-Ctrl-1 MII-Ctrl
- GSM9059037 MII-Ctrl-2 MII-Ctrl
- GSM9059038 MII-Ctrl-3 MII-Ctrl
- GSM9059039 MII-TGFb-1 MII-TGFb
- GSM9059040 MII-TGFb-2 MII-TGFb
- GSM9059041 MII-TGFb-3 MII-TGFb
- GSM9059042 SLUG-KO-1 SLUG-KO
- GSM9059043 SLUG-KO-2 SLUG-KO
- GSM9059044 SLUG-KO-3 SLUG-KO
- GSM9059045 MDA-MB-231-WT-1 MDA-MB-231-WT
- GSM9059046 MDA-MB-231-WT-2 MDA-MB-231-WT
- GSM9059047 MDA-MB-231-WT-3 MDA-MB-231-WT
- GSM9059048 ATAC_MI-Ctrl-1 ATAC_MI-Ctrl
- GSM9059049 ATAC_MI-Ctrl-2 ATAC_MI-Ctrl
- GSM9059050 ATAC_MI-Ctrl-3 ATAC_MI-Ctrl
- GSM9059051 ATAC_MI-Ctrl-4 ATAC_MI-Ctrl
- GSM9059052 ATAC_MI-TGF1-1 ATAC_MI-TGF1
- GSM9059053 ATAC_MI-TGF1-2 ATAC_MI-TGF1
- GSM9059054 ATAC_MI-TGF1-3 ATAC_MI-TGF1
- GSM9059055 ATAC_MI-TGF1-4 ATAC_MI-TGF1
- GSM9059056 ATAC_MII-Ctrl-1 ATAC_MII-Ctrl
- GSM9059057 ATAC_MII-Ctrl-2 ATAC_MII-Ctrl
- GSM9059058 ATAC_MII-Ctrl-3 ATAC_MII-Ctrl
- GSM9059059 ATAC_MII-Ctrl-4 ATAC_MII-Ctrl
- GSM9059060 ATAC_MII-TGF1-1 ATAC_MII-TGF1
- GSM9059061 ATAC_MII-TGF1-2 ATAC_MII-TGF1
- GSM9059062 ATAC_MII-TGF1-3 ATAC_MII-TGF1
- GSM9059063 ATAC_MII-TGF1-4 ATAC_MII-TGF1
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares progression, resistance
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares tgf
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing
- GSE325486 ESR1 mutations shape the clonal dynamics, genetic diversity and cellular states of acquired resistance to CDK4/6 inhibitors 57 samples shares cdk4, resistance, inhibitor
- GSE268699 Genes expression alterations associated with resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer 18 samples shares cdk4, resistance, inhibitor
- GSE298567 Single-Cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines 14 samples shares cdk4, resistance, inhibitor
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.